Category: News
-
Subcutaneous Immunotherapy: Patient Convenience or Patent Hopping?
April 2, 2026. A new article published from BG Lab in Journal of Clinical Oncology questions if new approvals of subcutaneous formulations of immunotherapy drugs are truly for patients’ convenience or simply a strategy of patent hopping. This paper was led by Dr. Laure-Anne Teuwen from BG Lab with senior author Dr. Bishal Gyawali and…
-
Meet the New BG Lab Virtual Cancer Groundshot Fellow: Dr. Javier-David Benítez-Fuentes
March 11, 2026. BG Lab is excited to announce our second BG Lab Virtual Cancer Groundshot Fellow, Dr. Javier-David Benítez-Fuentes. Dr. Javier-David Benítez-Fuentes is a consultant medical oncologist at Hospital General Universitario de Elche in Spain, specialised in thoracic malignancies. He completed his medical oncology training at Hospital Clínico San Carlos in Madrid, followed by a…
-
Dr. Bishal Gyawali Leads the New ASCO Guidelines on use of WBC Growth Factors
March 1, 2026. Dr. Gyawali is the first author and a co-chair for the newly published ASCO Guidelines on the use of white blood cell (WBC) colony stimulating factors in patients with cancer receiving systemic treatment. These guidelines were published in the Journal of Clinical Oncology. These updated guidelines help shared decision making among patients,…
-
Meet the First General Practitioner in Oncology Fellow of Nepal: Dr. Bishrut Sapkota
February 23, 2026. This January, we enrolled our first GPO fellow in Nepal, Dr. Bishrut Sapkota. In this story, we get to know more about the GPO fellowship program and Dr. Sapkota. One of the main global oncology focuses of BG Lab has been Nepal, given the roots of our PI Dr. Bishal Gyawali, who…
-
Meet the First BG Lab Cancer Groundshot Virtual Fellow: Dr. Syeda Mina
January 23, 2026. Today, BG Lab is excited to announce our first BG Lab Cancer Groundshot Fellow, Dr. Syeda Mina. Dr. Mina is a hematology and medical oncology fellow at Mayo Clinic in Rochester, Minnesota and will be graduating in July. She completed her medical training at Alfaisal University in Saudi Arabia, and her internal…
-
BG Lab Released Their 2025 Annual Report
BG Lab released their first annual report for the 2025 year! We had an amazing year full of mentoring, forming connections with experts across the globe, welcoming new trainees, and celebrating trainee milestones. This year was very productive for us – we produced 27 peer-reviewed publications, delivered 24 presentations, and our PI Dr. Bishal Gyawali…
-
Dr. Bishal Gyawali Honoured as Highly Ranked Scholar by ScholarGPS
ScholarGPS recognized Dr. Gyawali as a Highly Ranked Scholar in the specialties of Global Oncology and Progression-Free Survival. Highly Ranked Scholar is based on a quantitative assessment and recognizes scholars for their exceptional productivity, impact, and quality of scholarly contributions that have placed them in the top 0.05% of scholars worldwide. Dr. Gyawali was ranked…
-
A Case for Superiority Design De-Escalation Trials
Dr. Gyawali recently published a thought-provoking article in JNCI making a compelling case for using superiority design rather than noninferiority design to test de-escalation strategies in cancer care. Graphical abstract by Laure-Anne Teuwen Overtreatment is a growing concern in cancer care, where patients who may not benefit are being treated, or treatment may begin earlier,…
Dr. Bishal Gyawali 